Avanos Medical, Inc. (AVNS) Tops Q2 EPS by 5c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Avanos Medical (AVNS) PT Raised to $24 at Stifel
July 31, 2024 3:42 PM EDTStifel analyst Rick Wise raised the price target on Avanos Medical (NYSE: AVNS) to $24.00 (from $20.00) while maintaining a Hold rating.
The analyst comments "Avanos delivered a solid 2Q24 performance, as sales and EPS both exceeded our/Consensus estimates. 2024 sales, gross margin, and EPS... More
